Our Publications

  1. The Administration of Levodopa in a Patient With Parkinson’s Disease Using a Novel Maxillofacial Route: A First-in-Human Report. Cureus. 2023 Oct 30;15(10):e48011. https://doi.org/10.7759/cureus.48011
  2. Protein Drug Delivery Using a Novel Maxillofacial Technique Targeting the Visual Pathway in the Brain, the Optic Nerve, and the Retina. ACS Chemical Neuroscience. 2023;14(18):3368-3384. https://doi.org/10.1021/acschemneuro.3c00184
  3. New technique and device for controlled and continuous drug delivery into the brain: a proof-of-concept study. BMJ Innovations. 2021;7:470-477. http://dx.doi.org/10.1136/bmjinnov-2019-000393
  4. SARS-CoV-2: The Road Less Traveled—From the Respiratory Mucosa to the Brain. ACS Omega. 2021;6 (10):7068-7072. https://doi.org/10.1021/acsomega.1c00030
  5. Pulmonary Edema in COVID19—A Neural Hypothesis. ACS Chemical Neuroscience. 2020;11(14):2048-2050. https://doi.org/10.1021/acschemneuro.0c00370
  6. Cytokine Storm in COVID19: A Neural Hypothesis. ACS Chemical Neuroscience. 2020;11(13):1868-1870. https://doi.org/10.1021/acschemneuro.0c00346
  7. Happy Hypoxemia in COVID-19—A Neural Hypothesis. ACS Chemical Neuroscience. 2020;11(13):1865-1867. https://doi.org/10.1021/acschemneuro.0c00318
  8. C Reactive Protein based early intervention for home quarantined COVID-19 patients to avoid complications and hospitalization. medRxiv 2021.06.22.21258712. https://doi.org/10.1101/2021.06.22.21258712
  9. A Novel Maxillofacial Technology for Drug Administration-A Randomized Controlled Trial Using Metronidazole. medRxiv 2024.09.11.24313269. https://doi.org/10.1101/2024.09.11.24313269

International Posters

  1. International Congress of Parkinson’s Disease and Movement Disorders, Philadelphia, USA, 2024 – “24 Hour Maxillofacial Administration of Levodopa in a Parkinsons Patient -An Alternative Route of Administration in Parkinsons Disease.”
  2. 34th International Conference of Alzheimer’s Disease International, Singapore -2020 – “A Novel Device to Deliver Drugs Across the Blood Brain Barrier.”
  3. 34th International Conference of Alzheimer’s Disease International, Singapore -2020 – “Covid-19 & The Brain – A Neural Hypothesis.”